Revenue

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023	Apr '22 Apr 29, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 24, 2020	Apr '19 Apr 26, 2019	Apr '18 Apr 27, 2018	Apr '17 Apr 28, 2017	Apr '16 Apr 29, 2016	Apr '15 Apr 24, 2015	Apr '14 Apr 25, 2014	Apr '13 Apr 26, 2013
Cardiac Rhythm & Heart Failure Revenue	8.01B	7.50B	6.39B
Structural Heart & Aortic Revenue	-	3.82B	3.55B
Coronary & Peripheral Vascular Revenue	-	2.66B	2.54B
Cardiovascular Revenue	14.62B	13.98B	12.48B
Cranial & Spinal Technologies Revenue	5.38B	5.22B	4.97B
Specialty Therapies Revenue	3.07B	3.00B	2.94B
Neuromodulation Revenue	2.10B	2.07B	1.93B
Neuroscience Revenue	10.55B	10.29B	9.85B
Surgical & Endoscopy Revenue	6.89B	6.76B	6.50B
Acute Care & Monitoring Revenue	2.12B	2.05B	1.91B
Medical Surgical Revenue	9.01B	8.82B	8.41B
Diabetes Revenue	3.23B	3.11B	2.76B
Other Segment Revenue	130.00M	174.00M	48.00M
Revenue (Other)	1.00M	-	-
Revenue (Total)	37.54B	36.36B	33.54B

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023	Apr '22 Apr 29, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 24, 2020	Apr '19 Apr 26, 2019	Apr '18 Apr 27, 2018	Apr '17 Apr 28, 2017	Apr '16 Apr 29, 2016	Apr '15 Apr 24, 2015	Apr '14 Apr 25, 2014	Apr '13 Apr 26, 2013
U.S. Revenue	18.79B	18.10B	17.17B
Non-U.S. Developed Markets Revenue	-	-	10.20B
Emerging Markets Revenue	-	-	6.20B
Total International Revenue	18.76B	18.26B	16.37B
Revenue (Other)	-1.00M	-	1.00M
Revenue (Total)	37.54B	36.36B	33.54B

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023	Apr '22 Apr 29, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 24, 2020	Apr '19 Apr 26, 2019	Apr '18 Apr 27, 2018	Apr '17 Apr 28, 2017	Apr '16 Apr 29, 2016	Apr '15 Apr 24, 2015	Apr '14 Apr 25, 2014	Apr '13 Apr 26, 2013
Cardiovascular Operating Profit	3.88B	3.67B	3.34B
Neuroscience Operating Profit	3.15B	3.06B	3.03B
Medical Surgical Operating Profit	2.12B	2.13B	2.07B
Other Segment Operating Profit	-	106.00M	214.00M
Operating Income (Other)	-2.36B	-2.50B	-2.71B
Operating Income (Total)	6.79B	6.47B	5.96B

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023	Apr '22 Apr 29, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 24, 2020	Apr '19 Apr 26, 2019	Apr '18 Apr 27, 2018	Apr '17 Apr 28, 2017	Apr '16 Apr 29, 2016	Apr '15 Apr 24, 2015	Apr '14 Apr 25, 2014	Apr '13 Apr 26, 2013
Cardiovascular Organic Revenue Growth	9.30%	6.30%
Neuroscience Organic Revenue Growth	3.10%	5.20%
Medical Surgical Organic Revenue Growth	2.90%	0.80%
Diabetes Organic Revenue Growth	7.90%	11.50%
Total Organic Revenue Growth	5.80%	4.90%